As of Oct 17
| -0.63 / -0.32%|
The 19 analysts offering 12-month price forecasts for Allergan have a median target of 266.00, with a high estimate of 400.00 and a low estimate of 220.00. The median estimate represents a +34.49% increase from the last price of 197.78.
The current consensus among 23 polled investment analysts is to Buy stock in Allergan. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.